Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 15, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences Inc
| -1.81K |
$133.07 | -$240,995.73 | -27.01% | 4.89K |
Feb 13
|
Scheduled
| ||||||
Neurocrine Biosciences Inc
| -1.78K |
$138.69 | -$244,563.90 | -15.42% | 9.79K |
Feb 6 - Feb 8
|
Scheduled
| ||||||
Neurocrine Biosciences Inc
| -2.10K |
$140.80 | -$295,115.14 | -29.99% | 4.89K |
Jan 31
|
Scheduled
| ||||||
Neurocrine Biosciences Inc
| -1.44K |
$112.68 | -$161,921.16 | -22.70% | 4.89K |
Oct 2
| |||||||
Neurocrine Biosciences Inc
| -2.73K |
$107.60 | -$294,058.45 | -44.13% | 3.46K |
Aug 30
| |||||||
Neurocrine Biosciences Inc
| -1.60K |
$107.41 | -$171,862.08 | -20.53% | 6.19K |
Aug 21
| |||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 13
| |||||||
Neurocrine Biosciences Inc
| -25.24K |
$104.05 | -$2,586,741.39 | -65.99% | 13.01K |
Feb 6 - Feb 8
|
Scheduled
| ||||||
Neurocrine Biosciences Inc
| -1.10K |
$109.92 | -$121,348.59 | -22.01% | 3.91K |
Jan 31
|
Scheduled
| ||||||
Neurocrine Biosciences Inc
| -1.29K |
$114.12 | -$147,785.40 | -30.73% | 2.92K |
Oct 31
|
Scheduled
| ||||||
Neurocrine Biosciences Inc
| -1.44K |
$106.59 | -$153,169.83 | -25.43% | 4.21K |
Oct 3
|
Scheduled
| ||||||
Neurocrine Biosciences Inc
| -940.00 |
$80.35 | -$75,192.83 | -15.28% | 5.21K |
Feb 7 - Feb 8
|
Scheduled
| ||||||
Neurocrine Biosciences Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||